What is the appropriate enoxaparin dose in international units for a 50‑kg patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Enoxaparin Dosing for a 50kg Patient

For a 50kg patient, the appropriate enoxaparin dose depends entirely on the clinical indication, but for the most common scenarios: give 50mg (5,000 IU) subcutaneously every 12 hours for acute coronary syndrome initial therapy, or 50mg (5,000 IU) subcutaneously once daily for VTE prophylaxis in hospitalized medical/surgical patients.

Clinical Context Determines the Dose

The question asks about "Units" which requires understanding that 1mg of enoxaparin = 100 IU (International Units). Therefore, dosing calculations must account for both the indication and patient weight.

For Acute Coronary Syndromes (ACS)

Initial therapy for ACS uses 1 mg/kg subcutaneously every 12 hours 1, 2, 1, 2. For a 50kg patient:

  • Dose: 50mg (5,000 IU) subcutaneously every 12 hours
  • This applies to both STEMI and NSTE-ACS when enoxaparin is chosen as the anticoagulant
  • Important caveat: If creatinine clearance <30 mL/min, reduce to 1 mg/kg (50mg or 5,000 IU) once daily instead of twice daily 1, 2

With fibrinolytic therapy in patients <75 years: The dosing differs slightly with a 30mg IV bolus followed 15 minutes later by 1 mg/kg subcutaneously every 12 hours, with a maximum of 100mg for the first two doses 1, 2. For a 50kg patient, this would be 30mg IV bolus, then 50mg (5,000 IU) subcutaneously every 12 hours—well below the 100mg cap.

To support PCI: If the patient has not received prior anticoagulation, give 0.5-0.75 mg/kg IV bolus 1, 2, 3. For a 50kg patient, this equals 25-37.5mg (2,500-3,750 IU) IV bolus 3, 4.

For VTE Prophylaxis

Standard prophylactic dosing in hospitalized medical or surgical patients is 40mg once daily 5, 6. However, for a 50kg patient who is at the lower end of normal weight, the 40mg (4,000 IU) once daily dose remains appropriate 5, 6.

For surgical patients, alternative regimens exist depending on timing relative to surgery, but the maintenance dose remains 40mg once daily 5, 6.

For VTE Treatment

Therapeutic dosing for established VTE is 1 mg/kg every 12 hours or 1.5 mg/kg once daily 5, 6. For a 50kg patient:

  • 50mg (5,000 IU) every 12 hours, OR
  • 75mg (7,500 IU) once daily

The once-daily regimen may be preferred for convenience, though both are acceptable 5, 6.

Critical Dosing Considerations

Renal Function is Paramount

If creatinine clearance <30 mL/min, all twice-daily regimens must be reduced to once-daily dosing 1, 2, 5, 2, 6. This is non-negotiable to prevent accumulation and bleeding risk.

Weight Extremes

While 50kg is at the lower end of typical adult weight, it does not require dose adjustment for most indications. The 2025 ACC/AHA guidelines specify a maximum of 100mg for the first two doses when using enoxaparin with fibrinolytics in patients <75 years 1, 2, but a 50kg patient receiving 1 mg/kg would only get 50mg—well within safe limits.

Recent evidence suggests that extremely underweight patients (<40kg) may benefit from weight-based dosing with anti-Xa monitoring 7, but at 50kg, standard weight-based dosing is appropriate.

Available Formulations

Enoxaparin is available in prefilled syringes of 30mg, 40mg, 60mg, 80mg, 100mg, 120mg, and 150mg 8. For a 50kg patient requiring 50mg doses, you would use the 60mg syringe and waste 10mg, or use a vial formulation if available to draw exact doses.

Common Pitfalls to Avoid

  1. Do not switch between enoxaparin and UFH mid-treatment—this significantly increases bleeding risk 9, 3
  2. Do not give additional enoxaparin if the last subcutaneous dose was within 8 hours when proceeding to PCI 1, 2, 3
  3. Do not use fixed 30mg or 40mg dosing for ACS—weight-based dosing (1 mg/kg) is required for therapeutic anticoagulation 1, 2
  4. Do not forget to adjust for severe renal impairment—this is the most common cause of enoxaparin-related bleeding 10

Summary by Indication

Indication Dose for 50kg Patient Frequency Units (IU)
ACS initial therapy 50mg Every 12h SC 5,000 IU
ACS with CrCl <30 50mg Once daily SC 5,000 IU
VTE prophylaxis 40mg Once daily SC 4,000 IU
VTE treatment 50mg or 75mg Every 12h or once daily SC 5,000 or 7,500 IU
PCI support (no prior anticoagulation) 25-37.5mg Single IV bolus 2,500-3,750 IU

References

Research

Use of weight-based dosing of enoxaparin for venous thromboembolism prophylaxis in an extremely underweight elderly patient.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.